Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2001
08/01/2001EP1119557A1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
08/01/2001EP1119551A1 Naphthalenecarboxamides as tachykinin receptor antagonists
08/01/2001EP1119548A1 Pyrrole-2,5-diones as gsk-3 inhibitors
08/01/2001EP1119355A1 Naphthalenecarboxamides as tachykinin receptor antagonists
08/01/2001CN1306531A Epothilones derivatives, their synthesis and uses
08/01/2001CN1306525A Carboxylic acid of aza-heterocyclic compounds contg. multiple hetero-atoms or its electronic isosteric object
08/01/2001CN1306523A Substituted 6-aryl-3-thioxo-5-(thi) oxo-2,3,4,5-tetrahydro-1,2,4-triazines
08/01/2001CN1306516A Dihydrotriazolone derivatives as pesticides
08/01/2001CN1305995A Method for preparing 1,4-dihydropyridine compound
08/01/2001CN1305993A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor
08/01/2001CN1305989A Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same
08/01/2001CN1305812A N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
07/2001
07/31/2001USRE37303 Administering to warm-blooded animals imidazole derivative for inducing antagonist activity of h.sub.3 histamine receptors
07/31/2001US6268508 For crop protection
07/31/2001US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases
07/31/2001US6268389 Treatment of urinary incontinence by administration of α1L-adrenoceptor agonists
07/31/2001US6268365 Src family SH2 domain inhibitors
07/31/2001US6268363 Antitumor
07/31/2001US6268308 Herbicidal S-substituted 1,2,4,6-thiatriazines
07/31/2001CA2282890C Therapeutic heterocyclic compounds
07/26/2001WO2001053296A1 Method for producing heterocyclic compounds
07/26/2001WO2001053288A1 Novel piperidine compounds and drugs containing the same
07/26/2001WO2001053273A1 3-aminoquinazolin-2,4-dione antibacterial agents
07/26/2001WO2001053271A1 Imidazole compounds and their use as adenosine deaminase inhibitors
07/26/2001WO2001053267A1 Compounds exhibiting thrombopoietin receptor agonism
07/26/2001WO2001053263A1 Corticotropin releasing factor antagonists
07/26/2001WO2001053259A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
07/26/2001WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
07/26/2001WO2001052852A1 Water soluble prodrugs of azole compounds
07/26/2001WO2001052849A1 Remedies for diabetes
07/26/2001WO2001052847A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
07/26/2001WO2001052845A1 Gyrase inhibitors and uses thereof
07/26/2001WO2001046180A8 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
07/26/2001US20010009915 Nitrogen oxide yielding and thromboxane A2 (TXA2) and serotonin (5HT2) receptor antagonist; treatment of atherothrombotic cardiovascular disorders
07/26/2001US20010009911 Isomers, hydrates, solvates and addition salts in treatment of endothelial dysfunction disease such as atherosclerosis, dyslipidaemia; antidiabetic agents; heart transplantation; inhibition of nitrogen monoxide synthase and oxidative stress
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/26/2001CA2398388A1 Novel piperidine compound and pharmaceutical thereof
07/26/2001CA2397686A1 Gyrase inhibitors and uses thereof
07/26/2001CA2397633A1 Corticotropin releasing factor antagonists
07/26/2001CA2397627A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
07/26/2001CA2397008A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
07/25/2001EP1118610A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
07/25/2001EP1117663A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
07/25/2001EP1117661A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof
07/25/2001EP1117659A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/25/2001EP1117655A1 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
07/25/2001EP1117649A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/25/2001EP1117645A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use
07/25/2001EP1117642A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
07/25/2001EP0876366B1 Angiogenesis inhibiting pyridazinamines
07/25/2001EP0873319B1 Quinazoline derivatives
07/25/2001CN1305485A Monomeric, oligomeric acid polymeric knoevenagel condensation products
07/25/2001CN1305476A 1,3-oxazoline and 1,3-thiazoline derivatives, method for producing the same and their use as pesticides
07/25/2001CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein
07/25/2001CN1305472A Novel 2,5-pyridinedicarboxylic acid derivatives
07/25/2001CN1305471A Dihydropyrimidines
07/25/2001CN1305470A Amidine compounds
07/25/2001CN1305467A Phthalazine derivatives phosphodiesterase 4 inhibitors
07/25/2001CN1305462A Novel 1,5 and 3-O-substituted 1H-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, and method for the production and use thereof as medica
07/25/2001CN1304930A Arylsulfurylisooximino acid derivative
07/24/2001US6265584 Water soluble prodrugs of azole compounds
07/24/2001US6265583 Cyclic sulfone containing retroviral protease inhibitors
07/24/2001US6265581 Reacting specified epoxide and amine, reacting product with acid to form acid addition salt
07/24/2001US6265436 Substituted 5-biphenyl-3,4-dihydroxy-2(5H)-furanones and method of use therefor
07/24/2001US6265434 Antiinflammatory agents
07/24/2001US6265425 Side effect reduction; retinoic acid metabolism blocking agent
07/24/2001US6265419 Irritable bowel disorder
07/24/2001US6265408 Sulphonamide derivatives and their use in the treatment of CNS disorders
07/24/2001US6265407 Wound healing agents; antitumor agents
07/24/2001US6265404 Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
07/24/2001US6265399 Alkylation; cyclization
07/24/2001US6265352 Substituted carbamoyl triazoles and their use as herbicides
07/24/2001US6265351 Phenylpyrazoles with a herbicidal activity
07/24/2001US6265350 1,3-oxazoline and 1,3-thiazoline derivatives, their preparation, and their use as pesticides
07/24/2001US6265349 Pyridone derivatives and herbicides
07/24/2001CA2218503C Arylsulfonyl hydroxamic acid derivatives
07/24/2001CA2171972C Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
07/24/2001CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents
07/24/2001CA2030162C Benzothiazepines
07/19/2001WO2001051479A2 Tricyclic compounds with antiviral activity
07/19/2001WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists
07/19/2001WO2001005758A3 Indoles and indazoles for the treatment of migraine
07/19/2001WO2000076984A8 Novel compounds, their use and preparation
07/19/2001WO2000076970A3 Serine protease inhibitors
07/19/2001US20010008902 Reduction of an unsaturated thiazolidine-2,4-dione derivative with metallic aluminum in a protic solvent; purity; antidiabetic agents
07/19/2001US20010008892 Amide substituted thiazole derivatives
07/19/2001CA2396560A1 Tricyclic compounds and method of treating herpes virus
07/19/2001CA2396007A1 Piperidine and piperazine derivatives
07/18/2001EP1115722A1 SUBSTITUTED THIAZOL(IN) YLIDENEAMINO SULFONYLAMINO (THIO)CARBONYl -TRIAZOLINONES
07/18/2001EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
07/18/2001EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
07/18/2001EP1115718A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
07/18/2001EP1115712A1 Oxazole compounds as prostaglandin e2 agonists or antagonists
07/18/2001EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors
07/18/2001EP1115400A1 Benzothiazole dioxetanes
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily
07/18/2001CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
07/18/2001CN1304307A 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
07/18/2001CN1068596C Pesticidal tris-oximino heterocyclic compounds